The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis

Cancer Microenvironment

Volumn 5, Issue 1, 2012, Pages 5-18

  Heinrich, Eileen L ^a   Walser, Tonya C ^a   Krysan, Kostyantyn ^a   Liclican, Elvira L ^a   Grant, Jeanette L ^a   Rodriguez, Nicole L ^a   Dubinett, Steven M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

E cadherin; Inflammation; NSCLC

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MICRORNA; PROSTAGLANDIN E2; SCATTER FACTOR; TOBACCO SMOKE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VASCULOTROPIN;

CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER STEM CELL; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENETIC RISK; HUMAN; HYPOXIA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

EID: 84860633659     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-011-0089-0     Document Type: Review

References (163)

1. SS Barbieri BB Weksler 2007 Tobacco smoke cooperates with interleukin-1beta to alter beta-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo FASEB J 21 1831 1843 17317723 1:CAS:528: DC%2BD2sXmsVWksrc%3D 10.1096/fj.06-7557com (Pubitemid 46855629)
2. S Zienolddiny D Ryberg V Maggini V Skaug F Canzian, et al. 2004 Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer Int J Cancer 109 353 356 14961572 1:CAS:528:DC%2BD2cXhvVOgt7Y%3D 10.1002/ijc.11695 (Pubitemid 38252762)
3. A Mantovani P Allavena A Sica F Balkwill 2008 Cancer-related inflammation Nature 454 436 444 18650914 1:CAS:528:DC%2BD1cXovV2mtbg%3D 10.1038/nature07205
4. H Kuper HO Adami D Trichopoulos 2000 Infections as a major preventable cause of human cancer J Intern Med 248 171 183 10971784 1:STN:280: DC%2BD3cvps1Cqtw%3D%3D 10.1046/j.1365-2796.2000.00742.x (Pubitemid 33702479)
5. CH Koehne RN Dubois 2004 COX-2 inhibition and colorectal cancer Semin Oncol 31 12 21 15252926 1:CAS:528:DC%2BD2cXls1Oltbs%3D 10.1053/j.seminoncol. 2004.03.041 (Pubitemid 38879410)
6. PM Rothwell FG Fowkes JF Belch H Ogawa CP Warlow, et al. 2011 Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 31 41 21144578 1:CAS:528:DC%2BC3MXms1Wk 10.1016/S0140-6736(10)62110-1
7. RN Apte Y Krelin X Song S Dotan E Recih, et al. 2006 Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions Eur J Cancer 42 751 759 16530403 1:CAS:528:DC%2BD28Xjs1GrtL4%3D 10.1016/j.ejca.2006.01.010
8. F Colotta P Allavena A Sica C Garlanda A Mantovani 2009 Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 1073 1081 19468060 1:CAS:528:DC%2BD1MXot1CisL8%3D 10.1093/carcin/bgp127
9. O De Wever M Mareel 2003 Role of tissue stroma in cancer cell invasion J Pathol 200 429 447 12845611 10.1002/path.1398 1:CAS:528:DC%2BD3sXnvF2ns7s%3D (Pubitemid 36818244)
10. Giatromanolaki A, Sivridis E, Koukourakis MI (2007) The Pathology of Tumor Stromatogenesis. Cancer Biol Ther 6
11. T Akashi J Minami Y Ishige Y Eishi T Takizawa, et al. 2005 Basement membrane matrix modifies cytokine interactions between lung cancer cells and fibroblasts Pathobiology 72 250 259 16374069 1:CAS:528:DC%2BD2MXhtlCks7jN 10.1159/000089419 (Pubitemid 43004468)
12. R Kalluri M Zeisberg 2006 Fibroblasts in cancer Nat Rev Cancer 6 392 401 16572188 1:CAS:528:DC%2BD28XjslGitLw%3D 10.1038/nrc1877
13. D Fukumura R Xavier T Sugiura Y Chen EC Park, et al. 1998 Tumor induction of VEGF promoter activity in stromal cells Cell 94 715 725 9753319 1:CAS:528:DyaK1cXmtlCjs7o%3D 10.1016/S0092-8674(00)81731-6 (Pubitemid 28436004)
14. S Pokutta WI Weis 2007 Structure and mechanism of cadherins and catenins in cell-cell contacts Annu Rev Cell Dev Biol 23 237 261 17539752 1:CAS:528:DC%2BD2sXhtlartr3O 10.1146/annurev.cellbio.22.010305.104241
15. JP Thiery 2003 Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 15 740 746 14644200 1:CAS:528: DC%2BD3sXptlyks7c%3D 10.1016/j.ceb.2003.10.006 (Pubitemid 37487967)
16. M Guarino 2007 Epithelial-mesenchymal transition and tumour invasion Int J Biochem Cell Biol 39 2153 2160 17825600 1:CAS:528:DC%2BD2sXhtFWgsL%2FP 10.1016/j.biocel.2007.07.011 (Pubitemid 47484287)
17. KJ O'Byrne AG Dalgleish 2001 Chronic immune activation and inflammation as the cause of malignancy Br J Cancer 85 473 483 11506482 10.1054/bjoc.2001. 1943 (Pubitemid 32808267)
18. V Kim TJ Rogers GJ Criner 2008 New concepts in the pathobiology of chronic obstructive pulmonary disease Proc Am Thorac Soc 5 478 485 18453359 1:CAS:528:DC%2BD1cXmsV2gtro%3D 10.1513/pats.200802-014ET (Pubitemid 351669174)
19. JM Samet 2000 Does idiopathic pulmonary fibrosis increase lung cancer risk? Am J Respir Crit Care Med 161 1 2 10619788 1:STN:280: DC%2BD3c%2Fosleitg%3D%3D (Pubitemid 30055893)
20. PJ Wipff B Hinz 2008 Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship Eur J Cell Biol 87 601 615 18342983 1:CAS:528:DC%2BD1cXht1Ciu7fN 10.1016/j.ejcb.2008.01.012
21. J Massague 2008 TGFbeta in Cancer Cell 134 215 230 18662538 1:CAS:528:DC%2BD1cXptlaltbk%3D 10.1016/j.cell.2008.07.001 (Pubitemid 352010335)
22. BC Willis Z Borok 2007 TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease Am J Physiol Lung Cell Mol Physiol 293 L525 L534 17631612 1:CAS:528:DC%2BD2sXhtVOqsbjP 10.1152/ajplung.00163.2007 (Pubitemid 47358808)
23. YE Zhang 2009 Non-Smad pathways in TGF-beta signaling Cell Res 19 128 139 19114990 1:CAS:528:DC%2BD1MXht1GhsQ%3D%3D 10.1038/cr.2008.328
24. IY Adamson L Young DH Bowden 1988 Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis Am J Pathol 130 377 383 3341452 1:STN:280:DyaL1c7jtFalsQ%3D%3D (Pubitemid 18076372)
25. AB Roberts LM Wakefield 2003 The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci U S A 100 8621 8623 12861075 1:CAS:528:DC%2BD3sXlvVyisL8%3D 10.1073/pnas.1633291100 (Pubitemid 36899145)
26. PM Siegel W Shu RD Cardiff WJ Muller J Massague 2003 Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Acad Sci U S A 100 8430 8435 12808151 1:CAS:528:DC%2BD3sXlsFGntLc%3D 10.1073/pnas.0932636100 (Pubitemid 36842562)
27. Y Shintani M Maeda N Chaika KR Johnson MJ Wheelock 2008 Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling Am J Respir Cell Mol Biol 38 95 104 17673689 1:CAS:528:DC%2BD1cXhsVertg%3D%3D 10.1165/rcmb.2007-0071OC
28. S Thuault U Valcourt M Petersen G Manfioletti CH Heldin, et al. 2006 Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition J Cell Biol 174 175 183 16831886 1:CAS:528:DC%2BD28XntFaqsbo%3D 10.1083/jcb.200512110 (Pubitemid 44079853)
29. BB Aggarwal 2003 Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 745 756 12949498 1:CAS:528: DC%2BD3sXmvVWmtb0%3D 10.1038/nri1184 (Pubitemid 41070815)
30. S Mukhopadhyay JR Hoidal TK Mukherjee 2006 Role of TNFalpha in pulmonary pathophysiology Respir Res 7 125 17034639 10.1186/1465-9921-7-125 1:CAS:528:DC%2BD28Xht1WgsL7N (Pubitemid 44637860)
31. Y Wu J Deng PG Rychahou S Qiu BM Evers, et al. 2009 Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion Cancer Cell 15 416 428 19411070 1:CAS:528:DC%2BD1MXmvVGitrs%3D 10.1016/j.ccr.2009.03.016
32. C Min SF Eddy DH Sherr GE Sonenshein 2008 NF-kappaB and epithelial to mesenchymal transition of cancer J Cell Biochem 104 733 744 18253935 1:CAS:528:DC%2BD1cXntlWhtbo%3D 10.1002/jcb.21695 (Pubitemid 351830825)
33. JM Lee J Yanagawa KA Peebles S Sharma JT Mao, et al. 2008 Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment Crit Rev Oncol Hematol 66 208 217 18304833 10.1016/j.critrevonc.2008.01.004
34. RN Dubois SB Abramson L Crofford RA Gupta LS Simon, et al. 1998 Cyclooxygenase in biology and disease FASEB J 12 1063 1073 9737710 1:CAS:528:DyaK1cXlvFWntbY%3D (Pubitemid 28418937)
35. K Krysan KL Reckamp H Dalwadi S Sharma E Rozengurt, et al. 2005 Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner Cancer Res 65 6275 6281 16024629 1:CAS:528:DC%2BD2MXmt1egsL0%3D 10.1158/0008-5472.CAN-05-0216 (Pubitemid 40994413)
36. T Hida Y Yatabe H Achiwa H Muramatsu K Kozaki, et al. 1998 Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas Cancer Res 58 3761 3764 9731479 1:CAS:528:DyaK1cXlvVyrtbk%3D (Pubitemid 28405625)
37. K Krysan H Dalwadi S Sharma M Pold S Dubinett 2004 Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer Cancer Res 64 6359 6362 15374938 1:CAS:528: DC%2BD2cXnsFOlt70%3D 10.1158/0008-5472.CAN-04-1681 (Pubitemid 39297884)
38. F Baratelli Y Lin L Zhu SC Yang N Heuze-Vourc'h, et al. 2005 Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells J Immunol 175 1483 1490 16034085 1:CAS:528: DC%2BD2MXmtlWjtrc%3D (Pubitemid 41023048)
39. M Dohadwala RK Batra J Luo Y Lin K Krysan, et al. 2002 Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2- dependent invasion J Biol Chem 277 50828 50833 12393872 1:CAS:528: DC%2BD38Xps12ntb0%3D 10.1074/jbc.M210707200 (Pubitemid 36042248)
40. M Dohadwala SC Yang J Luo S Sharma RK Batra, et al. 2006 Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer Cancer Res 66 5338 5345 16707460 1:CAS:528:DC%2BD28XksF2isbw%3D 10.1158/0008-5472.CAN- 05-3635 (Pubitemid 43844959)
41. C Birchmeier W Birchmeier E Gherardi GF Vande Woude 2003 Met, metastasis, motility and more Nat Rev Mol Cell Biol 4 915 925 14685170 1:CAS:528: DC%2BD3sXpvFeju7s%3D 10.1038/nrm1261 (Pubitemid 37493640)
42. J Taipale J Keski-Oja 1997 Growth factors in the extracellular matrix FASEB J 11 51 59 9034166 1:CAS:528:DyaK2sXhtFaksLo%3D (Pubitemid 27076324)
43. L Trusolino A Bertotti PM Comoglio 2010 MET signalling: principles and functions in development, organ regeneration and cancer Nat Rev Mol Cell Biol 11 834 848 21102609 1:CAS:528:DC%2BC3cXhsVGrurfI 10.1038/nrm3012
44. C Birchmeier E Gherardi 1998 Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase Trends Cell Biol 8 404 410 9789329 1:CAS:528:DyaK1cXmvFWjur8%3D 10.1016/S0962-8924(98)01359-2 (Pubitemid 28458706)
45. Trusolino L, Bertotti A, Comoglio PM MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11: 834-848
46. JM Siegfried LA Weissfeld JD Luketich RJ Weyant CT Gubish, et al. 1998 The clinical significance of hepatocyte growth factor for non-small cell lung cancer Ann Thorac Surg 66 1915 1918 9930468 1:STN:280:DyaK1M7islKmug%3D%3D 10.1016/S0003-4975(98)01165-5 (Pubitemid 29087181)
47. JM Siegfried JD Luketich LP Stabile N Christie SR Land 2004 Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung Chest 125 116S 119S 15136456 1:CAS:528:DC%2BD2cXkvFChs7o%3D 10.1378/chest.125.5-suppl.116S (Pubitemid 38648345)
48. S Grotegut D von Schweinitz G Christofori F Lehembre 2006 Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail EMBO J 25 3534 3545 16858414 1:CAS:528:DC%2BD28XnvVGlsrc%3D 10.1038/sj.emboj.7601213 (Pubitemid 44264864)
49. G Li H Schaider K Satyamoorthy Y Hanakawa K Hashimoto, et al. 2001 Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development Oncogene 20 8125 8135 11781826 1:CAS:528:DC%2BD3MXptlKktbg%3D 10.1038/sj.onc.1205034 (Pubitemid 34028337)
50. SL Kominsky P Argani D Korz E Evron V Raman, et al. 2003 Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast Oncogene 22 2021 2033 12673207 1:CAS:528:DC%2BD3sXisFKgs74%3D 10.1038/sj.onc.1206199 (Pubitemid 36523639)
51. L Toschi PA Janne 2008 Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer Clin Cancer Res 14 5941 5946 18829470 1:CAS:528:DC%2BD1cXhtF2nur3E 10.1158/1078-0432.CCR-08-0071
52. RL Yauch T Januario DA Eberhard G Cavet W Zhu, et al. 2005 Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients Clin Cancer Res 11 8686 8698 16361555 1:CAS:528:DC%2BD2MXhtlWrsb3L 10.1158/1078-0432.CCR-05-1492 (Pubitemid 43005918)
53. SE Witta RM Gemmill FR Hirsch CD Coldren K Hedman, et al. 2006 Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines Cancer Res 66 944 950 16424029 1:CAS:528:DC%2BD28XlsFOquw%3D%3D 10.1158/0008-5472.CAN-05-1988 (Pubitemid 43165962)
54. JA Engelman K Zejnullahu T Mitsudomi Y Song C Hyland, et al. 2007 MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling Science 316 1039 1043 17463250 1:CAS:528:DC%2BD2sXltlOjt7g%3D 10.1126/science.1141478 (Pubitemid 46799492)
55. K Krysan JM Lee M Dohadwala BK Gardner KL Reckamp, et al. 2008 Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance J Thorac Oncol 3 107 110 18303428 10.1097/JTO.0b013e3181630ece (Pubitemid 351323182)
56. RN Apte E Voronov 2002 Interleukin-1-a major pleiotropic cytokine in tumor-host interactions Semin Cancer Biol 12 277 290 12147202 1:CAS:528:DC%2BD38XlvVSjsLo%3D 10.1016/S1044-579X(02)00014-7 (Pubitemid 35034572)
57. A Colasante N Mascetra M Brunetti G Lattanzio M Diodoro, et al. 1997 Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors Am J Respir Crit Care Med 156 968 973 9310021 1:STN:280:DyaK2svlsFyjsg%3D%3D (Pubitemid 27396443)
58. S Tu G Bhagat G Cui S Takaishi EA Kurt-Jones, et al. 2008 Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice Cancer Cell 14 408 419 18977329 1:CAS:528:DC%2BD1cXhtlOjsLrP 10.1016/j.ccr.2008.10.011
59. Y Krelin E Voronov S Dotan M Elkabets E Reich, et al. 2007 Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors Cancer Res 67 1062 1071 17283139 1:CAS:528:DC%2BD2sXht1yns7k%3D 10.1158/0008-5472.CAN-06-2956
60. R Giavazzi A Garofalo MR Bani M Abbate P Ghezzi, et al. 1990 Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice Cancer Res 50 4771 4775 2196116 1:CAS:528:DyaK3cXkvFGqsbo%3D (Pubitemid 20230427)
61. T Walser X Cui J Yanagawa JM Lee E Heinrich, et al. 2008 Smoking and lung cancer: the role of inflammation Proc Am Thorac Soc 5 811 815 19017734 10.1513/pats.200809-100TH
62. AM Lewis S Varghese H Xu HR Alexander 2006 Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment J Transl Med 4 48 17096856 10.1186/1479-5876-4-48 (Pubitemid 44848821)
63. GL Semenza 2010 Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 625 634 19946328 1:CAS:528: DC%2BD1MXhsV2gt77N 10.1038/onc.2009.441
64. AL Harris 2002 Hypoxia-a key regulatory factor in tumour growth Nat Rev Cancer 2 38 47 11902584 1:CAS:528:DC%2BD38XhvF2jtL4%3D 10.1038/nrc704 (Pubitemid 37328806)
65. V Nizet RS Johnson 2009 Interdependence of hypoxic and innate immune responses Nat Rev Immunol 9 609 617 19704417 1:CAS:528:DC%2BD1MXhtVersbvK 10.1038/nri2607
66. SF Fitzpatrick MM Tambuwala U Bruning B Schaible CC Scholz, et al. 2011 An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia J Immunol 186 1091 1096 21149600 1:CAS:528:DC%2BC3MXjs1KqsA%3D%3D 10.4049/jimmunol.1002256
67. WY Kim S Perera B Zhou J Carretero JJ Yeh, et al. 2009 HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice J Clin Invest 119 2160 2170 19662677 1:CAS:528:DC%2BD1MXpsFCluro%3D 10.1172/JCI38443
68. DF Higgins K Kimura WM Bernhardt N Shrimanker Y Akai, et al. 2007 Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to- mesenchymal transition J Clin Invest 117 3810 3820 18037992 1:CAS:528: DC%2BD2sXhsValsL7F (Pubitemid 350224091)
69. MA Esteban MG Tran SK Harten P Hill MC Castellanos, et al. 2006 Regulation of E-cadherin expression by VHL and hypoxia-inducible factor Cancer Res 66 3567 3575 16585181 1:CAS:528:DC%2BD28XjtVOrs7w%3D 10.1158/0008-5472.CAN- 05-2670
70. B Krishnamachary D Zagzag H Nagasawa K Rainey H Okuyama, et al. 2006 Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B Cancer Res 66 2725 2731 16510593 1:CAS:528: DC%2BD28XhvV2gsL0%3D 10.1158/0008-5472.CAN-05-3719
71. MH Yang MZ Wu SH Chiou PM Chen SY Chang, et al. 2008 Direct regulation of TWIST by HIF-1alpha promotes metastasis Nat Cell Biol 10 295 305 18297062 1:CAS:528:DC%2BD1cXislaksrc%3D 10.1038/ncb1691 (Pubitemid 351331016)
72. EH Gort G van Haaften I Verlaan AJ Groot RH Plasterk, et al. 2008 The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha Oncogene 27 1501 1510 17873906 1:CAS:528:DC%2BD1cXivFyrsbo%3D 10.1038/sj.onc.1210795 (Pubitemid 351347879)
73. JJ Hung MH Yang HS Hsu WH Hsu JS Liu, et al. 2009 Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer Thorax 64 1082 1089 19778933 10.1136/thx.2009.115691
74. D Luo J Wang J Li M Post 2011 Mouse snail is a target gene for HIF Mol Cancer Res 9 234 245 21257819 1:CAS:528:DC%2BC3MXitVWlsL8%3D 10.1158/1541-7786.MCR-10-0214
75. C Sahlgren MV Gustafsson S Jin L Poellinger U Lendahl 2008 Notch signaling mediates hypoxia-induced tumor cell migration and invasion Proc Natl Acad Sci U S A 105 6392 6397 18427106 1:CAS:528:DC%2BD1cXlsFyhtbs%3D 10.1073/pnas.0802047105 (Pubitemid 351758356)
76. J Chen N Imanaka JD Griffin 2010 Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion Br J Cancer 102 351 360 20010940 1:CAS:528: DC%2BC3cXntlKitw%3D%3D 10.1038/sj.bjc.6605486
77. S Pennacchietti P Michieli M Galluzzo M Mazzone S Giordano, et al. 2003 Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 347 361 12726861 10.1016/S1535-6108(03)00085-0 (Pubitemid 38340304)
78. YG Jiang Y Luo DL He X Li LL Zhang, et al. 2007 Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha Int J Urol 14 1034 1039 17956532 1:CAS:528:DC%2BD1cXjs1Wmuw%3D%3D 10.1111/j.1442-2042.2007.01866.x (Pubitemid 47621827)
79. G Zhou LA Dada M Wu A Kelly H Trejo, et al. 2009 Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1 Am J Physiol Lung Cell Mol Physiol 297 L1120 L1130 19801454 1:CAS:528:DC%2BD1MXhsFOgtrzI 10.1152/ajplung.00007.2009
80. Y Chen D Li H Liu H Xu H Zheng, et al. 2011 Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells Cancer Biol Ther 11 14 21 20962575 1:CAS:528:DC%2BC3MXislyhtL4%3D 10.4161/cbt.11.1.13730
81. JT Erler KL Bennewith M Nicolau N Dornhofer C Kong, et al. 2006 Lysyl oxidase is essential for hypoxia-induced metastasis Nature 440 1222 1226 16642001 1:CAS:528:DC%2BD28XjvVGltb8%3D 10.1038/nature04695
82. CH Huang WH Yang SY Chang SK Tai CH Tzeng, et al. 2009 Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis Neoplasia 11 1371 1382 20019845 1:CAS:528:DC%2BD1MXhsFejurnO
83. YG Yoo J Christensen LE Huang 2011 HIF-1alpha confers aggressive malignant traits on human tumor cells independent of its canonical transcriptional function Cancer Res 71 1244 1252 21303984 1:CAS:528: DC%2BC3MXhvFSjsL4%3D 10.1158/0008-5472.CAN-10-2360
84. A Albini F Tosetti R Benelli DM Noonan 2005 Tumor inflammatory angiogenesis and its chemoprevention Cancer Res 65 10637 10641 16322203 1:CAS:528:DC%2BD2MXht1Gqu7bP 10.1158/0008-5472.CAN-05-3473 (Pubitemid 41713327)
85. M Pold LX Zhu S Sharma MD Burdick Y Lin, et al. 2004 Cyclooxygenase-2- dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer Cancer Res 64 1853 1860 14996749 1:CAS:528:DC%2BD2cXhslersrs%3D 10.1158/0008-5472.CAN-03-3262 (Pubitemid 38428711)
86. M Tsujii S Kawano S Tsuji H Sawaoka M Hori, et al. 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 705 716 9630216 1:CAS:528:DyaK1cXjsl2ksbw%3D 10.1016/S0092-8674(00)81433-6 (Pubitemid 28257578)
87. M Tsujii S Kawano RN DuBois 1997 Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc Natl Acad Sci U S A 94 3336 3340 9096394 1:CAS:528:DyaK2sXisVKnsr8%3D 10.1073/pnas.94.7.3336 (Pubitemid 27157312)
88. M Dohadwala J Luo L Zhu Y Lin GJ Dougherty, et al. 2001 Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44 J Biol Chem 276 20809 20812 11320076 1:CAS:528:DC%2BD3MXksFGlsr4%3D 10.1074/jbc.C100140200
89. G Giannelli C Bergamini E Fransvea C Sgarra S Antonaci 2005 Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma Gastroenterology 129 1375 1383 16285938 1:CAS:528:DC%2BD2MXht12hu7fI 10.1053/j.gastro.2005.09.055 (Pubitemid 41597379)
90. J Yanagawa TC Walser LX Zhu L Hong MC Fishbein, et al. 2009 Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma Clin Cancer Res 15 6820 6829 19887480 1:CAS:528:DC%2BD1MXhtl2ktLzP 10.1158/1078-0432.CCR-09-1558
91. A Yuan PC Yang CJ Yu WJ Chen FY Lin, et al. 2000 Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer Am J Respir Crit Care Med 162 1957 1963 11069840 1:STN:280: DC%2BD3M%2FkvF2huw%3D%3D
92. RM Strieter 2008 Out of the shadows: CXC chemokines in promoting aberrant lung cancer angiogenesis Cancer Prev Res (Phila) 1 305 307 1:CAS:528: DC%2BC3cXptFOitro%3D 10.1158/1940-6207.CAPR-08-0168
93. H Sun WC Chung SH Ryu Z Ju HT Tran, et al. 2008 Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis Cancer Prev Res (Phila) 1 316 328 1:CAS:528:DC%2BC3cXptFOitrg%3D 10.1158/1940-6207.CAPR-07-0002
94. M Wislez N Fujimoto JG Izzo AE Hanna DD Cody, et al. 2006 High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras Cancer Res 66 4198 4207 16618742 1:CAS:528: DC%2BD28XjsFSlt7Y%3D 10.1158/0008-5472.CAN-05-3842
95. PE Framson EH Sage 2004 SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92 679 690 15211566 1:CAS:528:DC%2BD2cXlslenurw%3D 10.1002/jcb.20091 (Pubitemid 44264259)
96. G Robert C Gaggioli O Bailet C Chavey P Abbe, et al. 2006 SPARC represses E-cadherin and induces mesenchymal transition during melanoma development Cancer Res 66 7516 7523 16885349 1:CAS:528:DC%2BD28XnsFyrtbk%3D 10.1158/0008-5472.CAN-05-3189 (Pubitemid 44289206)
97. T Seno H Harada S Kohno M Teraoka A Inoue, et al. 2009 Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas Int J Oncol 34 707 715 19212676 1:CAS:528:DC%2BD1MXjs1Kgsb8%3D 10.3892/ijo-00000197
98. CA Klein 2009 Parallel progression of primary tumours and metastases Nat Rev Cancer 9 302 312 19308069 1:CAS:528:DC%2BD1MXjsFSrsr8%3D 10.1038/nrc2627
99. O De Wever P Demetter M Mareel M Bracke 2008 Stromal myofibroblasts are drivers of invasive cancer growth Int J Cancer 123 2229 2238 18777559 10.1002/ijc.23925 1:CAS:528:DC%2BD1cXhtleiurvF
100. N Sato N Maehara M Goggins 2004 Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts Cancer Res 64 6950 6956 15466186 1:CAS:528:DC%2BD2cXotFals7k%3D 10.1158/0008-5472.CAN-04-0677 (Pubitemid 39331004)
101. RG Rowe SJ Weiss 2008 Breaching the basement membrane: who, when and how? Trends Cell Biol 18 560 574 18848450 1:CAS:528:DC%2BD1cXht12gtLzE 10.1016/j.tcb.2008.08.007
102. K Polyak RA Weinberg 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 265 273 19262571 1:CAS:528:DC%2BD1MXis1Chtb0%3D 10.1038/nrc2620
103. JI Yook XY Li I Ota ER Fearon SJ Weiss 2005 Wnt-dependent regulation of the E-cadherin repressor snail J Biol Chem 280 11740 11748 15647282 1:CAS:528:DC%2BD2MXisVyjtLY%3D 10.1074/jbc.M413878200 (Pubitemid 40418488)
104. BP Zhou J Deng W Xia J Xu YM Li, et al. 2004 Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition Nat Cell Biol 6 931 940 15448698 1:CAS:528:DC%2BD2cXnvFGqs7o%3D 10.1038/ncb1173 (Pubitemid 39359846)
105. I Ota XY Li Y Hu SJ Weiss 2009 Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1 Proc Natl Acad Sci U S A 106 20318 20323 19915148 1:CAS:528: DC%2BC3cXjtFSqsg%3D%3D 10.1073/pnas.0910962106
106. F Sabeh I Ota K Holmbeck H Birkedal-Hansen P Soloway, et al. 2004 Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP J Cell Biol 167 769 781 15557125 1:CAS:528:DC%2BD2cXhtVaqtb3J 10.1083/jcb.200408028 (Pubitemid 39565156)
107. HC Lien YH Hsiao YS Lin YT Yao HF Juan, et al. 2007 Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition Oncogene 26 7859 7871 17603561 1:CAS:528:DC%2BD2sXhsVaisr%2FN 10.1038/sj.onc.1210593 (Pubitemid 350261788)
108. RA Brekken EH Sage 2001 SPARC, a matricellular protein: at the crossroads of cell-matrix communication Matrix Biol 19 816 827 11223341 1:STN:280:DC%2BD3Mzit1ygug%3D%3D 10.1016/S0945-053X(00)00133-5 (Pubitemid 32153838)
109. T Sasaki N Miosge R Timpl 1999 Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens Matrix Biol 18 499 508 10601737 1:CAS:528:DyaK1MXotFansL0%3D 10.1016/S0945-053X(99)00041-4
110. PM Tremble TF Lane EH Sage Z Werb 1993 SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway J Cell Biol 121 1433 1444 8509459 1:CAS:528:DyaK3sXksVKisb8%3D 10.1083/jcb.121.6.1433 (Pubitemid 23174558)
111. MF Ledda S Adris AI Bravo C Kairiyama L Bover, et al. 1997 Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells Nat Med 3 171 176 9018235 1:CAS:528:DyaK2sXpsVOmuw%3D%3D 10.1038/nm0297-171 (Pubitemid 27064701)
112. C Gilles JA Bassuk H Pulyaeva EH Sage JM Foidart, et al. 1998 SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines Cancer Res 58 5529 5536 9850090 1:CAS:528:DyaK1cXotVWis7g%3D (Pubitemid 28551141)
113. MI Koukourakis A Giatromanolaki RA Brekken E Sivridis KC Gatter, et al. 2003 Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients Cancer Res 63 5376 5380 14500371 1:CAS:528:DC%2BD3sXntlekuro%3D (Pubitemid 37139854)
114. JR Infante H Matsubayashi N Sato J Tonascia AP Klein, et al. 2007 Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma J Clin Oncol 25 319 325 17235047 10.1200/JCO.2006.07. 8824 (Pubitemid 350003021)
115. S Nomura S Hashmi JH McVey J Ham M Parker, et al. 1989 Evidence for positive and negative regulatory elements in the 5′-flanking sequence of the mouse sparc (osteonectin) gene J Biol Chem 264 12201 12207 2745436 1:CAS:528:DyaK3cXhslSrug%3D%3D (Pubitemid 19191103)
116. S Sangaletti E Di Carlo S Gariboldi S Miotti B Cappetti, et al. 2008 Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis Cancer Res 68 9050 9059 18974151 1:CAS:528:DC%2BD1cXhtlSkur3I 10.1158/0008-5472.CAN-08-1327
117. A Fire S Xu MK Montgomery SA Kostas SE Driver, et al. 1998 Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 806 811 9486653 1:CAS:528:DyaK1cXhtlCju74%3D 10.1038/35888 (Pubitemid 28099681)
118. L He GJ Hannon 2004 MicroRNAs: small RNAs with a big role in gene regulation Nat Rev Genet 5 522 531 15211354 1:CAS:528:DC%2BD2cXltVSmsbw%3D 10.1038/nrg1379 (Pubitemid 38868508)
119. PA Gregory CP Bracken AG Bert GJ Goodall 2008 MicroRNAs as regulators of epithelial-mesenchymal transition Cell Cycle 7 3112 3118 18927505 1:CAS:528:DC%2BD1cXhsV2mu7nL 10.4161/cc.7.20.6851
120. OA Kent JT Mendell 2006 A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes Oncogene 25 6188 6196 17028598 1:CAS:528:DC%2BD28XhtVGjsbbO 10.1038/sj.onc.1209913 (Pubitemid 44527849)
121. T Dalmay DR Edwards 2006 MicroRNAs and the hallmarks of cancer Oncogene 25 6170 6175 17028596 1:CAS:528:DC%2BD28XhtVGjsbbM 10.1038/sj.onc.1209911 (Pubitemid 44527847)
122. A Tanzer PF Stadler 2004 Molecular evolution of a microRNA cluster J Mol Biol 339 327 335 15136036 1:CAS:528:DC%2BD2cXjsl2ns78%3D 10.1016/j.jmb.2004.03. 065 (Pubitemid 38596952)
123. IK Oglesby NG McElvaney CM Greene 2010 MicroRNAs in inflammatory lung disease-master regulators or target practice? Respir Res 11 148 21029443 10.1186/1465-9921-11-148 1:CAS:528:DC%2BC3cXhsVWks73P
124. KA O'Donnell EA Wentzel KI Zeller CV Dang JT Mendell 2005 c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 839 843 15944709 10.1038/nature03677 1:CAS:528:DC%2BD2MXkvVGgsLg%3D (Pubitemid 40839736)
125. P Mu YC Han D Betel E Yao M Squatrito, et al. 2009 Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas Genes Dev 23 2806 2811 20008931 1:CAS:528:DC%2BC3cXntFKj 10.1101/gad.1872909
126. HB Houbaviy MF Murray PA Sharp 2003 Embryonic stem cell-specific MicroRNAs Dev Cell 5 351 358 12919684 1:CAS:528:DC%2BD3sXmvVCitLg%3D 10.1016/S1534-5807(03)00227-2 (Pubitemid 37006477)
127. Y Lu JM Thomson HY Wong SM Hammond BL Hogan 2007 Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells Dev Biol 310 442 453 17765889 1:CAS:528:DC%2BD2sXhtFSksrjJ 10.1016/j.ydbio.2007.08.007 (Pubitemid 47483685)
128. JW Kim S Mori JR Nevins 2010 Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate Cancer Res 70 4820 4828 20516112 1:CAS:528:DC%2BC3cXntlKltrg%3D 10.1158/0008-5472.CAN-10-0659
129. L Ma J Young H Prabhala E Pan P Mestdagh, et al. 2010 miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol 12 247 256 20173740 1:CAS:528:DC%2BC3cXisFems7g%3D
130. P Mestdagh E Fredlund F Pattyn JH Schulte D Muth, et al. 2009 MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors Oncogene 29 1394 1404 19946337 10.1038/onc.2009.429 1:CAS:528:DC%2BD1MXhsV2gt7%2FI
131. G Vetter A Saumet M Moes L Vallar A Le Bechec, et al. 2010 miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers Oncogene 29 4436 4448 20543867 1:CAS:528:DC%2BC3cXntlSjsLY%3D 10.1038/onc.2010.181
132. L Ma J Teruya-Feldstein RA Weinberg 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 682 688 17898713 1:CAS:528:DC%2BD2sXhtFChurfF 10.1038/nature06174 (Pubitemid 47552092)
133. CL Cottonham S Kaneko L Xu 2010 miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells J Biol Chem 285 35293 35302 20826792 1:CAS:528:DC%2BC3cXhtlyntLrN 10.1074/jbc.M110.160069
134. Schramedei K, Morbt N, Pfeifer G, Lauter J, Rosolowski M, et al. (2011) MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene
135. H Valadi K Ekstrom A Bossios M Sjostrand JJ Lee, et al. 2007 Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 654 659 17486113 1:CAS:528: DC%2BD2sXmtVSmtb8%3D 10.1038/ncb1596 (Pubitemid 47214727)
136. A Ginestra D Miceli V Dolo FM Romano ML Vittorelli 1999 Membrane vesicles in ovarian cancer fluids: a new potential marker Anticancer Res 19 3439 3445 10629632 1:STN:280:DC%2BD3c%2FpsFSqtA%3D%3D (Pubitemid 30000200)
137. A Yuan EL Farber AL Rapoport D Tejada R Deniskin, et al. 2009 Transfer of microRNAs by embryonic stem cell microvesicles PLoS One 4 e4722 19266099 10.1371/journal.pone.0004722 1:CAS:528:DC%2BD1MXjtFOqu7s%3D
138. V Muralidharan-Chari JW Clancy A Sedgwick C D'Souza-Schorey 2010 Microvesicles: mediators of extracellular communication during cancer progression J Cell Sci 123 1603 1611 20445011 1:CAS:528:DC%2BC3cXotFGrsLw%3D 10.1242/jcs.064386
139. PS Mitchell RK Parkin EM Kroh BR Fritz SK Wyman, et al. 2008 Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 10513 10518 18663219 1:CAS:528:DC%2BD1cXpsVCltL0%3D 10.1073/pnas.0804549105
140. JC Brase D Wuttig R Kuner H Sultmann 2010 Serum microRNAs as non-invasive biomarkers for cancer Mol Cancer 9 306 21110877 1:CAS:528:DC%2BC3cXhsF2hs7rF 10.1186/1476-4598-9-306
141. BN Gomperts A Spira PP Massion TC Walser II Wistuba, et al. 2011 Evolving concepts in lung carcinogenesis Semin Respir Crit Care Med 32 32 43 21500122 10.1055/s-0031-1272867
142. JP Sullivan JD Minna JW Shay 2010 Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy Cancer Metastasis Rev 29 61 72 20094757 10.1007/s10555-010-9216-5
143. A Singh J Settleman 2010 EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 4741 4751 20531305 1:CAS:528:DC%2BC3cXntVSrur0%3D 10.1038/onc.2010.215
144. SA Mani W Guo M-J Liao EN Eaton A Ayyanan, et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 704 715 18485877 1:CAS:528:DC%2BD1cXmsVOru7w%3D 10.1016/j.cell.2008.03. 027 (Pubitemid 351636299)
145. CJ Creighton X Li M Landis JM Dixon VM Neumeister, et al. 2009 Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Proc Natl Acad Sci U S A 106 13820 13825 19666588 1:CAS:528:DC%2BD1MXhtFWksLjF 10.1073/pnas.0905718106
146. M Yu GA Smolen J Zhang B Wittner BJ Schott, et al. 2009 A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression Genes Dev 23 1737 1742 19651985 1:CAS:528:DC%2BD1MXps1ymt7Y%3D 10.1101/gad.1809309
147. MH Yang DS Hsu HW Wang HJ Wang HY Lan, et al. 2010 Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition Nat Cell Biol 12 982 992 20818389 10.1038/ncb2099 1:CAS:528:DC%2BC3cXht1aktb7N
148. Giannoni E, Bianchini F, Calorini L, Chiarugi P (2011) Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal.
149. Louie E, Nik S, Chen JS, Schmidt M, Song B, et al. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 12: R94
150. KA Kurrey NK SA Bapat 2005 Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level Gynecol Oncol 97 155 165 15790452 10.1016/j.ygyno.2004.12.043 1:CAS:528:DC%2BD2MXis1Grsb4%3D (Pubitemid 40403688)
151. AV Pinho I Rooman FX Real 2011 p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells Cell Cycle 10 1312 1321 21490434 1:CAS:528:DC%2BC3MXhs1SqsrfM 10.4161/cc.10.8.15363
152. CJ Chang CH Chao W Xia JY Yang Y Xiong, et al. 2011 p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs Nat Cell Biol 13 317 323 21336307 1:CAS:528:DC%2BC3MXisFKntrg%3D 10.1038/ncb2173
153. R May SM Sureban N Hoang TE Riehl SA Lightfoot, et al. 2009 Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively Stem Cells 27 2571 2579 19676123 1:CAS:528:DC%2BD1MXhsFenurzO 10.1002/stem.193
154. SM Sureban R May S Ramalingam D Subramaniam G Natarajan, et al. 2009 Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism Gastroenterology 137 649 659 19445940 1:CAS:528:DC%2BD1MXhtVKrtr%2FM 10.1053/j.gastro.2009.05.004 659 e641-642
155. Sureban SM, May R, Lightfoot SA, Hoskins AB, Lerner M, et al. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res 71: 2328-2338
156. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol.
157. S Brabletz K Bajdak S Meidhof U Burk G Niedermann, et al. 2011 The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells EMBO J 30 770 782 21224848 1:CAS:528:DC%2BC3MXjslWrsg%3D%3D 10.1038/emboj.2010.349
158. CS Tellez DE Juri K Do AM Bernauer CL Thomas, et al. 2011 EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells Cancer Res 71 3087 3097 21363915 1:CAS:528:DC%2BC3MXkslWjsLc%3D 10.1158/0008-5472.CAN-10-3035
159. H Kitamura K Okudela T Yazawa H Sato H Shimoyamada 2009 Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer Lung Cancer 66 275 281 19716622 10.1016/j.lungcan.2009.07.019
160. B Aktas M Tewes T Fehm S Hauch R Kimmig, et al. 2009 Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Res 11 R46 19589136 10.1186/bcr2333 1:CAS:528:DC%2BD1MXoslSlu7w%3D
161. JP Sullivan M Spinola M Dodge MG Raso C Behrens, et al. 2010 Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling Cancer Res 70 9937 9948 21118965 1:CAS:528:DC%2BC3cXhsFamurjF 10.1158/0008-5472.CAN-10-0881
162. RJ Soberman P Christmas 2006 Revisiting prostacyclin: new directions in pulmonary fibrosis and inflammation Am J Physiol Lung Cell Mol Physiol 291 L142 L143 16581828 1:CAS:528:DC%2BD28XovVWgu7w%3D 10.1152/ajplung.00102.2006 (Pubitemid 44148097)
163. M Tomaki H Sugiura A Koarai Y Komaki T Akita, et al. 2007 Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung Pulm Pharmacol Ther 20 596 605 16919984 1:CAS:528:DC%2BD2sXnvFyks7g%3D 10.1016/j.pupt.2006.06.006 (Pubitemid 47077652)